Arizona Liver Health

Recent publications and citations

Top Concepts

Top subject area publications in last 5 years

Collaboration Analysis

Publications from 2021 to 2026

Latest Publications

Filter IconFilter

Showing 10 of 25 papers

  • Open Access
  • Research Article

Resmetirom: An Update on Therapy for Metabolic Dysfunction-Associated Steatohepatitis (MASH).

  • Jan 01, 2026
  • Drug design, development and therapy
  • Laurens A Van Kleef +4
  • Research Article
  • Citations7

Predictors of fibrosis, clinical events, and mortality in MASLD: Data from the Global-MASLD study.

  • Nov 13, 2025
  • Hepatology (Baltimore, Md.)
  • Zobair M Younossi +85
  • Open Access
  • Research Article
  • Citations99

Global Consensus Recommendations for Metabolic Dysfunction-Associated Steatotic Liver Disease and Steatohepatitis.

  • Oct 01, 2025
  • Gastroenterology
  • Zobair M Younossi +42
  • Conference Article
  • Citations1

P4 Treatment with resmetirom for up to two years led to improvement in liver stiffness, fibrosis biomarkers, fibrosis scores and portal hypertension risk in 122 patients with compensated MASH cirrhosis

  • Oct 01, 2025
  • Phil Newsome +6
  • Open Access
  • PDF
  • Research Article
  • Citations8

TERN-501 monotherapy and combination therapy with TERN-101 in metabolic dysfunction-associated steatohepatitis: the randomized phase 2a DUET trial.

  • Jun 11, 2025
  • Nature medicine
  • Mazen Noureddin +12
  • Open Access
  • Research Article
  • Citations2

Design and rationale for a global novel non-invasive screening observational study using genetics and non-invasive methodologies to identify at-risk MASLD participants: The ALIGN study.

  • Apr 01, 2025
  • Contemporary clinical trials communications
  • Samuel J Daniels +11
  • Research Article
  • Citations3

Focused Recommendations for the Management of Metabolic Dysfunction-Associated Steatohepatitis (MASH) by Advanced Practice Providers in the United States.

  • Apr 01, 2025
  • Journal of clinical gastroenterology
  • Brian P Lam +9
  • Open Access
  • Supplementary Content
  • Citations19

Metabolic Dysfunction and Alcohol-Associated Liver Disease: A Narrative Review

  • Feb 19, 2025
  • Clinical and Translational Gastroenterology
  • Nicholas Dunn +3
  • Open Access
  • Research Article
  • Citations44

Disparities in steatosis prevalence in the United States by Race or Ethnicity according to the 2023 criteria

  • Oct 29, 2024
  • Communications Medicine
  • Luis Antonio Díaz +21
  • Abstract

S1971 Non-English Primary Language Linked to Increased Complications and Reduced Transplant Rates in Cirrhosis Patients: Insights From Population-Based Multi-network Analysis

  • Oct 01, 2024
  • American Journal of Gastroenterology
  • Khaled Alsabbagh Alchirazi +5
Cactus Communications logo

Copyright 2026 Cactus Communications. All rights reserved.